Axcelis Technologies (NASDAQ:ACLS – Get Free Report) updated its second quarter 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 1.380- for the period, compared to the consensus earnings per share estimate of 1.300. The company issued revenue guidance of $252.0 million-, compared to the consensus revenue estimate of $244.7 million. Axcelis Technologies also updated its Q2 guidance to above $1.38 EPS.
Analyst Ratings Changes
A number of brokerages recently commented on ACLS. Needham & Company LLC reaffirmed a hold rating on shares of Axcelis Technologies in a research report on Friday, May 3rd. Benchmark lowered their price objective on shares of Axcelis Technologies from $180.00 to $170.00 and set a buy rating on the stock in a research report on Friday, May 3rd. Craig Hallum raised shares of Axcelis Technologies from a hold rating to a buy rating and set a $130.00 price objective on the stock in a research report on Friday, May 3rd. Finally, B. Riley boosted their price objective on shares of Axcelis Technologies from $155.00 to $175.00 and gave the company a buy rating in a research report on Thursday, June 20th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of Moderate Buy and an average price target of $173.00.
Read Our Latest Analysis on Axcelis Technologies
Axcelis Technologies Stock Performance
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last posted its earnings results on Wednesday, May 1st. The semiconductor company reported $1.57 EPS for the quarter, topping the consensus estimate of $1.26 by $0.31. The company had revenue of $252.37 million during the quarter, compared to the consensus estimate of $242.55 million. Axcelis Technologies had a net margin of 22.16% and a return on equity of 30.22%. As a group, equities analysts anticipate that Axcelis Technologies will post 6.41 EPS for the current fiscal year.
Insiders Place Their Bets
In other Axcelis Technologies news, Director John T. Kurtzweil sold 1,200 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $114.42, for a total value of $137,304.00. Following the completion of the sale, the director now directly owns 33,146 shares of the company’s stock, valued at $3,792,565.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Featured Stories
- Five stocks we like better than Axcelis Technologies
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Top 2 Cybersecurity Stocks Booming in an Age of Rising Threats
- Consumer Discretionary Stocks Explained
- Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Uncover Why This Pharma Stock Jumped 400% on Study Update
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.